Your browser doesn't support javascript.
loading
Human endogenous retrovirus-R envelope is a host restriction factor against severe acute respiratory syndrome-coronavirus-2
Nidhi Gupta; Shabnam Ansari; Rohit Verma; Oinam N Singh; Mukesh Kumar Yadav; Akshay Binayke; Kamini Jakhar; Shailendra Mani; Amit Awasti; Shalimar; Baibaswata Nayak; CT Ranjith-Kumar; Milan Surjit.
Affiliation
  • Nidhi Gupta; Translational Health Science and Technology Institute
  • Shabnam Ansari; Translational Health Science Technology Institute
  • Rohit Verma; Translational Health Science Technology Institute
  • Oinam N Singh; Translational Health Science Technology Institute
  • Mukesh Kumar Yadav; Translational Health Science Technology Institute
  • Akshay Binayke; Translational Health Science Technology Institute
  • Kamini Jakhar; Transnational Health Science and Technology Institute
  • Shailendra Mani; Transnational Health Science and Technology Institute
  • Amit Awasti; Translational Health Science and Technology Institute
  • Shalimar; All India Institute of Medical Sciences
  • Baibaswata Nayak; All India Institute of Medical Sciences
  • CT Ranjith-Kumar; GGSIPU
  • Milan Surjit; Translational Health Science Technology Institute
Preprint in English | bioRxiv | ID: ppbiorxiv-502940
ABSTRACT
Coronavirus induced disease-19 (COVID-19), caused by the SARS-CoV-2 remains a major global health challenge. Human endogenous retroviruses (HERVs) represent retroviral elements that got integrated into the ancestral human genome. HERVs are important in development and diseases, including cancer, inflammation and viral infections. Here, we analyzed the expression of several HERVs in SARS-CoV-2 infected cells and observed increased activity of HERV-E, HERV-V, HERV-FRD, HERV-MER34, HERV-W and HERV-KHML2. In contrast, HERV-R-envelope was downregulated in cell-based models and COVID-19 patient PBMCs. HERV-R overexpression inhibited SARS-CoV-2 replication, suggesting its antiviral action. Further studies demonstrated the role of extracellular signal-regulated kinase (ERK) in regulating HERV-R antiviral activity. Cross-talk between the ERK and p38 MAPK controls HERV-R envelope synthesis, which in turn modulates the replication of SARS-CoV-2. These findings establish the importance of HERV-R envelope as a host restriction factor against SARS-CoV-2 and illustrate the advantage of integration and evolutionary maintenance of retroviral-elements in the human genome.
License
cc_no
Full text: Available Collection: Preprints Database: bioRxiv Type of study: Rct Language: English Year: 2022 Document type: Preprint
Full text: Available Collection: Preprints Database: bioRxiv Type of study: Rct Language: English Year: 2022 Document type: Preprint
...